PERISCOPE CAPITAL INC. - EUROPEAN BIOTECH ACQUTN CORP ownership

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBAC and the CUSIP is G3167F102. A total of 32 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PERISCOPE CAPITAL INC. ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q4 2022$7,845,650
-6.2%
776,797
-7.9%
0.34%
+39.1%
Q3 2022$8,362,000
+68.7%
843,223
+66.5%
0.24%
+84.1%
Q2 2022$4,958,000
+0.2%
506,4790.0%0.13%
+3.9%
Q1 2022$4,946,000
+0.7%
506,4790.0%0.13%
-3.8%
Q4 2021$4,913,000
+1101.2%
506,479
+1103.6%
0.13%
+1000.0%
Q3 2021$409,0000.0%42,0790.0%0.01%
-7.7%
Q2 2021$409,00042,0790.01%
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q2 2021
NameSharesValueWeighting ↓
Exos Asset Management LLC 45,300$441,0000.23%
MMCAP International Inc. SPC 250,000$2,435,0000.12%
Atalaya Capital Management LP 40,000$386,0000.10%
Radcliffe Capital Management, L.P. 200,000$1,942,0000.06%
Arena Capital Advisors, LLC- CA 75,000$731,0000.06%
FIR TREE CAPITAL MANAGEMENT LP 150,000$1,449,0000.05%
Athanor Capital, LP 147,800$1,428,0000.05%
Woodline Partners LP 275,000$2,654,0000.05%
Ghisallo Capital Management LLC 125,000$1,208,0000.05%
SUVRETTA CAPITAL MANAGEMENT, LLC 300,000$2,922,0000.04%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders